HHS - National Cannabis Roundtable Applauds 'Historic' HHS Recommendation To Reschedule Cannabis | Benzinga
Following the release of documents from the U.S. Department of Health and Human Services relating to the agency’s review of the federal classification of cannabis, the National Cannabis Roundtable (NCR) praised the acknowledgment by a federal agency that cannabis should be reclassified from a Schedule I to Schedule III substance under the Controlled Substances Act (CSA).
Since the October 6, 2022, directive by President Biden for federal agencies to review the appropriateness of cannabis being classified in the most restrictive schedule, the NCR, an alliance of cannabis companies has been instrumental in advocating for and informing the heads of the Department of Health and Human Services (HHS) and the DEA as to the scientific facts and medical value of cannabis meriting its reclassification to at least Schedule III.
"The importance of a federal agency publicly acknowledging that cannabis is ...